Surgery in soft tissue sarcoma: More conservative in extremities, more extended in the retroperitoneum

Chiara Colombo, R Randall, Robert Hi Andtbacka, Alessandro Gronchi

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

Extremity soft-tissue sarcomas (ESTS) account for approximately 50% and retroperitoneal soft-tissue sarcomas (RSTS) for approximately15% of all soft-tissue sarcomas. Surgery remains the main treatment modality for all soft-tissue sarcomas. Neoadjuvant and/or adjuvant chemo-and radiation-therapy are also often used to improve the treatment outcomes. In ESTS, surgery had originally been mutilating. The introduction of principles of surgical adequacy and of complementary treatments, especially radiotherapy, led to a reduction in the amputation rate in favor of conservative treatments. The implementation of plastic, vascular and nerve reconstructions allowed for further increase in conservative procedures, with better functional and cosmetic results. Moreover, recent reports have demonstrated how preoperative treatments can offset the negative prognostic impact of marginal resection on local outcome and survival, extending the limit of limb and function preservation. In RSTS, surgery had consisted of simple excision, while the resection of surrounding organs/viscera had been considered only in cases of direct involvement/infiltration. This strategy was associated with a high rate of local recurrence, which in many cases it was the driving cause of death. In order to improve local control and subsequent overall survival, some authors have recently advocated a policy of extended surgery including surrounding organs/viscera en bloc with the tumor. In this review, the authors discuss the standard world wide accepted surgical treatment for ESTS and the new surgical approach for RSTS.

Original languageEnglish (US)
Pages (from-to)1079-1087
Number of pages9
JournalExpert Review of Anticancer Therapy
Volume12
Issue number8
DOIs
StatePublished - Aug 1 2012
Externally publishedYes

Fingerprint

Sarcoma
Extremities
Viscera
Radiotherapy
Therapeutics
Amputation
Cosmetics
Plastics
Blood Vessels
Cause of Death
Recurrence
Neoplasms

Keywords

  • chemotherapy
  • extremity soft tissue sarcoma
  • prognosis
  • radiotherapy
  • retroperitoneal sarcoma
  • sarcoma
  • surgery

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

Cite this

Surgery in soft tissue sarcoma : More conservative in extremities, more extended in the retroperitoneum. / Colombo, Chiara; Randall, R; Andtbacka, Robert Hi; Gronchi, Alessandro.

In: Expert Review of Anticancer Therapy, Vol. 12, No. 8, 01.08.2012, p. 1079-1087.

Research output: Contribution to journalReview article

Colombo, Chiara ; Randall, R ; Andtbacka, Robert Hi ; Gronchi, Alessandro. / Surgery in soft tissue sarcoma : More conservative in extremities, more extended in the retroperitoneum. In: Expert Review of Anticancer Therapy. 2012 ; Vol. 12, No. 8. pp. 1079-1087.
@article{1b27ddf0b41b4f4087214913c8cc3983,
title = "Surgery in soft tissue sarcoma: More conservative in extremities, more extended in the retroperitoneum",
abstract = "Extremity soft-tissue sarcomas (ESTS) account for approximately 50{\%} and retroperitoneal soft-tissue sarcomas (RSTS) for approximately15{\%} of all soft-tissue sarcomas. Surgery remains the main treatment modality for all soft-tissue sarcomas. Neoadjuvant and/or adjuvant chemo-and radiation-therapy are also often used to improve the treatment outcomes. In ESTS, surgery had originally been mutilating. The introduction of principles of surgical adequacy and of complementary treatments, especially radiotherapy, led to a reduction in the amputation rate in favor of conservative treatments. The implementation of plastic, vascular and nerve reconstructions allowed for further increase in conservative procedures, with better functional and cosmetic results. Moreover, recent reports have demonstrated how preoperative treatments can offset the negative prognostic impact of marginal resection on local outcome and survival, extending the limit of limb and function preservation. In RSTS, surgery had consisted of simple excision, while the resection of surrounding organs/viscera had been considered only in cases of direct involvement/infiltration. This strategy was associated with a high rate of local recurrence, which in many cases it was the driving cause of death. In order to improve local control and subsequent overall survival, some authors have recently advocated a policy of extended surgery including surrounding organs/viscera en bloc with the tumor. In this review, the authors discuss the standard world wide accepted surgical treatment for ESTS and the new surgical approach for RSTS.",
keywords = "chemotherapy, extremity soft tissue sarcoma, prognosis, radiotherapy, retroperitoneal sarcoma, sarcoma, surgery",
author = "Chiara Colombo and R Randall and Andtbacka, {Robert Hi} and Alessandro Gronchi",
year = "2012",
month = "8",
day = "1",
doi = "10.1586/era.12.80",
language = "English (US)",
volume = "12",
pages = "1079--1087",
journal = "Expert Review of Anticancer Therapy",
issn = "1473-7140",
publisher = "Expert Reviews Ltd.",
number = "8",

}

TY - JOUR

T1 - Surgery in soft tissue sarcoma

T2 - More conservative in extremities, more extended in the retroperitoneum

AU - Colombo, Chiara

AU - Randall, R

AU - Andtbacka, Robert Hi

AU - Gronchi, Alessandro

PY - 2012/8/1

Y1 - 2012/8/1

N2 - Extremity soft-tissue sarcomas (ESTS) account for approximately 50% and retroperitoneal soft-tissue sarcomas (RSTS) for approximately15% of all soft-tissue sarcomas. Surgery remains the main treatment modality for all soft-tissue sarcomas. Neoadjuvant and/or adjuvant chemo-and radiation-therapy are also often used to improve the treatment outcomes. In ESTS, surgery had originally been mutilating. The introduction of principles of surgical adequacy and of complementary treatments, especially radiotherapy, led to a reduction in the amputation rate in favor of conservative treatments. The implementation of plastic, vascular and nerve reconstructions allowed for further increase in conservative procedures, with better functional and cosmetic results. Moreover, recent reports have demonstrated how preoperative treatments can offset the negative prognostic impact of marginal resection on local outcome and survival, extending the limit of limb and function preservation. In RSTS, surgery had consisted of simple excision, while the resection of surrounding organs/viscera had been considered only in cases of direct involvement/infiltration. This strategy was associated with a high rate of local recurrence, which in many cases it was the driving cause of death. In order to improve local control and subsequent overall survival, some authors have recently advocated a policy of extended surgery including surrounding organs/viscera en bloc with the tumor. In this review, the authors discuss the standard world wide accepted surgical treatment for ESTS and the new surgical approach for RSTS.

AB - Extremity soft-tissue sarcomas (ESTS) account for approximately 50% and retroperitoneal soft-tissue sarcomas (RSTS) for approximately15% of all soft-tissue sarcomas. Surgery remains the main treatment modality for all soft-tissue sarcomas. Neoadjuvant and/or adjuvant chemo-and radiation-therapy are also often used to improve the treatment outcomes. In ESTS, surgery had originally been mutilating. The introduction of principles of surgical adequacy and of complementary treatments, especially radiotherapy, led to a reduction in the amputation rate in favor of conservative treatments. The implementation of plastic, vascular and nerve reconstructions allowed for further increase in conservative procedures, with better functional and cosmetic results. Moreover, recent reports have demonstrated how preoperative treatments can offset the negative prognostic impact of marginal resection on local outcome and survival, extending the limit of limb and function preservation. In RSTS, surgery had consisted of simple excision, while the resection of surrounding organs/viscera had been considered only in cases of direct involvement/infiltration. This strategy was associated with a high rate of local recurrence, which in many cases it was the driving cause of death. In order to improve local control and subsequent overall survival, some authors have recently advocated a policy of extended surgery including surrounding organs/viscera en bloc with the tumor. In this review, the authors discuss the standard world wide accepted surgical treatment for ESTS and the new surgical approach for RSTS.

KW - chemotherapy

KW - extremity soft tissue sarcoma

KW - prognosis

KW - radiotherapy

KW - retroperitoneal sarcoma

KW - sarcoma

KW - surgery

UR - http://www.scopus.com/inward/record.url?scp=84867052464&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867052464&partnerID=8YFLogxK

U2 - 10.1586/era.12.80

DO - 10.1586/era.12.80

M3 - Review article

C2 - 23030226

AN - SCOPUS:84867052464

VL - 12

SP - 1079

EP - 1087

JO - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

SN - 1473-7140

IS - 8

ER -